Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm IncfiledCriticalMillennium Pharm Inc
Publication of ECSP13013059ApublicationCriticalpatent/ECSP13013059A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Se describen formulaciones de anticuerpo que comprenden una mezcla de un anticuerpo anti- 4 7, un antioxidante o quelante y al menos un aminoácido libre. Las formulaciones descritas pueden tener una estabilidad mejorada, una formación de agregados reducida o ambas.Antibody formulations comprising a mixture of an anti-4 7 antibody, an antioxidant or chelator and at least one free amino acid are described. The formulations described may have improved stability, reduced aggregate formation or both.
ECSP130130592011-05-022013-11-28
FORMULATION FOR ANTIBODY ANTI- 4 7
ECSP13013059A
(en)